Selective adenosine agonists and myocardial perfusion imaging

Blunting of the Heart Rate Response to Adenosine and Regadenoson in Relation to Hyperglycemia and the Metabolic Syndrome

(2010) Fadi G. Hage et al.   AMERICAN JOURNAL OF CARDIOLOGY

Recent developments in adenosine receptor ligands and their potential as novel drugs

(2010) Christa E. Müller et al.   BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES

The emerging role of the selective A2A agonist in pharmacologic stress testing

(2010) Anthony S. Gemignani et al.   JOURNAL OF NUCLEAR CARDIOLOGY

Lessons from regadenoson and low-level treadmill/regadenoson myocardial perfusion imaging: Initial clinical experience in 1263 patients

(2010) Deborah H. Kwon et al.   JOURNAL OF NUCLEAR CARDIOLOGY

Safety of regadenoson in patients with end-stage liver disease

(2010) Wael AlJaroudi et al.   JOURNAL OF NUCLEAR CARDIOLOGY

Differences in heart rate response to adenosine and regadenoson in patients with and without diabetes mellitus

(2009) Fadi G. Hage et al.   AMERICAN HEART JOURNAL

Safety of Regadenoson in Patients with End-Stage Renal Disease

(2009) Wael Aljaroudi et al.   AMERICAN JOURNAL OF CARDIOLOGY

Safety of Binodenoson, a Selective Adenosine A 2A Receptor Agonist Vasodilator Pharmacological Stress Agent, in Healthy Subjects With Mild Intermittent Asthma

(2009) John J. Murray et al.   Circulation-Cardiovascular Imaging

The RegEx trial: a randomized, double-blind, placebo- and active-controlled pilot study combining regadenoson, a selective A2A adenosine agonist, with low-level exercise, in patients undergoing myocardial perfusion imaging

(2009) Gregory S. Thomas et al.   JOURNAL OF NUCLEAR CARDIOLOGY

Regadenoson: A New Myocardial Stress Agent

(2009) Wael Al Jaroudi et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Effects of Adenosine and a Selective A2A Adenosine Receptor Agonist on Hemodynamic and Thallium-201 and Technetium-99m–SestaMIBI Biodistribution and Kinetics

(2009) Choukri Mekkaoui et al.   JACC-Cardiovascular Imaging

Regadenoson Induces Comparable Left Ventricular Perfusion Defects as Adenosine

(2009) John J. Mahmarian et al.   JACC-Cardiovascular Imaging

Regadenoson, a Novel Pharmacologic Stress Agent for Use in Myocardial Perfusion Imaging, Does Not Have a Direct Effect on the QT Interval in Conscious Dogs

(2008) Gong Zhao et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

Safety of regadenoson, an adenosine A2A receptor agonist for myocardial perfusion imaging, in mild asthma and moderate asthma patients: A randomized, double-blind, placebo-controlled trial

(2008) B LEAKER et al.   JOURNAL OF NUCLEAR CARDIOLOGY

Safety of regadenoson, a selective adenosine A2A agonist, in patients with chronic obstructive pulmonary disease: A randomized, double-blind, placebo-controlled trial (RegCOPD trial)

(2008) G THOMAS et al.   JOURNAL OF NUCLEAR CARDIOLOGY

Interaction of Caffeine With Regadenoson-Induced Hyperemic Myocardial Blood Flow as Measured by Positron Emission Tomography

(2008) Oliver Gaemperli et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Effects of Age, Gender, Obesity, and Diabetes on the Efficacy and Safety of the Selective A2A Agonist Regadenoson Versus Adenosine in Myocardial Perfusion Imaging

(2008) Manuel D. Cerqueira et al.   JACC-Cardiovascular Imaging